Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 4, 2012, Pages 1391-1403

  Lavie, Lena ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cardiovascular Morbidity; Endothelial Dysfunction; Inflammation; Obstructive Sleep Apnea; Oxidative Stress; Review

Indexed keywords

ASCORBIC ACID; C REACTIVE PROTEIN; CATALASE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; XANTHINE OXIDASE;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; APNEA HYPOPNEA INDEX; AROUSAL; ARTERIAL OXYGEN SATURATION; ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD OXYGEN TENSION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CELL FUNCTION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENERGY METABOLISM; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HYPERCAPNIA; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INTERMITTENT HYPOXIA; LIFESPAN; LIPID PEROXIDATION; MORBIDITY; NONHUMAN; OXIDATIVE STRESS; OXYGEN DESATURATION; OXYGEN TENSION; POSITIVE END EXPIRATORY PRESSURE; REOXYGENATION; REVIEW; SLEEP DISORDERED BREATHING; THORAX PRESSURE; UPREGULATION; VASODILATATION; PATHOPHYSIOLOGY; SLEEP APNEA SYNDROME; VASCULAR ENDOTHELIUM;

ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; OXIDATIVE STRESS; SLEEP APNEA SYNDROMES;

EID: 84860857234     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e469     Document Type: Review

References (138)

1. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber and S. Badr: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328, 1230-1235 (1993) (Pubitemid 23115702)
2. T. Young, E. Shahar, F. J. Nieto, S. Redline, A. B. Newman, D. J. Gottlieb, J. A. Walsleben, L. Finn, P. Enright and J. M. Samet: Predictors of sleep-disordered breathing in communitydwelling adults: the Sleep Heart Health Study. Arch Intern Med 162, 893-900 (2002) (Pubitemid 34299121)
3. N. M. Punjabi: The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5, 136-143 (2008) (Pubitemid 351237871)
4. T. Young, P. E. Peppard and D. J. Gottlieb: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165, 1217-1239 (2002) (Pubitemid 34461732)
5. A. S. Jordan and D. P. White: Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir Physiol Neurobiol 160, 1-7 (2008) (Pubitemid 350213545)
6. V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, T. G. Pickering, R. Russell, M. Woo and T. Young: Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118, 1080-1111 (2008)
7. R. L. Riha, K. Diefenbach, P. Jennum and W. T. McNicholas: Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoeahypopnoea syndrome. Sleep Med Rev 12, 49-63 (2008)
8. D. L. Carden and D. N. Granger: Pathophysiology of ischaemia-reperfusion injury. J Pathol 190, 255-266 (2000) (Pubitemid 30141372)
9. C. Guilleminault, F. L. Eldridge and W. C. Dement: Human pathology - sleep-induced apneas and cardio-vascular changes. Bull Physiopathol Respir (Nancy) 10, 244-247 (1974)
10. P. Lavie, R. Ben-Yosef and A. E. Rubin: Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 108, 373-376 (1984) (Pubitemid 14061382)
11. J. R. Stradling: Sleep apnoea and systemic hypertension. Thorax 44, 984-989 (1989) (Pubitemid 20020718)
12. P. Lavie, P. Herer and V. Hoffstein: Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Bmj 320, 479-482 (2000) (Pubitemid 30173118)
13. E. O. Bixler, A. N. Vgontzas, H. M. Lin, T. Ten Have, B. E. Leiby, A. Vela-Bueno and A. Kales: Association of hypertension and sleep-disordered breathing. Arch Intern Med 160, 2289-2295 (2000)
14. P. E. Peppard, T. Young, M. Palta and J. Skatrud: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342, 1378-1384 (2000) (Pubitemid 30262394)
15. F. Campos-Rodriguez, A. Grilo-Reina, J. Perez-Ronchel, M. Merino-Sanchez, M. A. Gonzalez-Benitez, M. Beltran-Robles and C. Almeida-Gonzalez: Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129, 1459-1467 (2006) (Pubitemid 43894973)
16. D. Brooks, R. L. Horner, L. F. Kozar, C. L. Render-Teixeira and E. A. Phillipson: Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99, 106-109 (1997) (Pubitemid 27058300)
17. P. Lavie, L. Lavie and P. Herer: All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 25, 514-520 (2005) (Pubitemid 40331183)
18. L. F. Drager, L. A. Bortolotto, C. Maki-Nunes, I. C. Trombetta, M. J. Alves, R. F. Fraga, C. E. Negrao, E. M. Krieger and G. Lorenzi-Filho: The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 208, 490-495 (2010)
19. F. J. Nieto, P. E. Peppard and T. B. Young: Sleep disordered breathing and metabolic syndrome. Wmj 108, 263-265 (2009)
20. P. Levy, M. R. Bonsignore and J. Eckel: Sleep, sleepdisordered breathing and metabolic consequences. Eur Respir J 34, 243-260 (2009)
21. J. A. Dempsey, S. C. Veasey, B. J. Morgan and C. P. O'Donnell: Pathophysiology of sleep apnea. Physiol Rev 90, 47-112 (2010)
22. V. K. Somers, A. L. Mark and F. M. Abboud: Sympathetic activation by hypoxia and hypercapnia - implications for sleep apnea. Clin Exp Hypertens A 10 Suppl 1, 413-422 (1988) (Pubitemid 19078441)
23. J. Hedner, B. Darpo, H. Ejnell, J. Carlson and K. Caidahl: Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8, 222-229 (1995)
24. J. M. McCord: The evolution of free radicals and oxidative stress. Am J Med 108, 652-659 (2000) (Pubitemid 30336605)
25. M. Valko, D. Leibfritz, J. Moncol, M. T. Cronin, M. Mazur and J. Telser: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39, 44-84 (2007) (Pubitemid 44566469)
26. L. Lavie: Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 7, 35-51 (2003) (Pubitemid 36188305)
27. B. D'Autreaux and M. B. Toledano: ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8, 813-824 (2007) (Pubitemid 47462134)
28. Y. J. Suzuki, H. J. Forman and A. Sevanian: Oxidants as stimulators of signal transduction. Free Radic Biol Med 22, 269-285 (1997) (Pubitemid 26399334)
29. J. S. Beckman and W. H. Koppenol: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271, C1424-1437 (1996)
30. M. B. Grisham, D. N. Granger and D. J. Lefer: Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 25, 404-433 (1998) (Pubitemid 28390298)
31. W. Droge: Free radicals in the physiological control of cell function. Physiol Rev 82, 47-95 (2002) (Pubitemid 34654215)
32. Lavie L. Intermittent hypoxia: the culprit of oxidative stress, vascular inflammation and dyslipidemia in obstructive sleep apnea. Expert Rev Resp Med 2, 75-84 (2008) (Pubitemid 352015324)
33. L. Lavie: Oxidative stress - a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 51, 303-312 (2009)
34. L. Lavie and P. Lavie: Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33, 1467-1484 (2009)
35. L. Dyugovskaya, P. Lavie and L. Lavie: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165, 934-939 (2002) (Pubitemid 34774660)
36. R. Schulz, S. Mahmoudi, K. Hattar, U. Sibelius, H. Olschewski, K. Mayer, W. Seeger and F. Grimminger: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162, 566-570 (2000) (Pubitemid 30647201)
37. L. Dyugovskaya, A. Polyakov, P. Lavie and L. Lavie: Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 177, 544-554 (2008) (Pubitemid 351442194)
38. L. Lavie, A. Vishnevsky and P. Lavie: Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27, 123-128 (2004) (Pubitemid 43906323)
39. A. Barcelo, C. Miralles, F. Barbe, M. Vila, S. Pons and A. G. Agusti: Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16, 644-647 (2000)
40. K. Christou, A. N. Moulas, C. Pastaka and K. I. Gourgoulianis: Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4, 225-228 (2003) (Pubitemid 36748608)
41. T. Kizawa, Y. Nakamura, S. Takahashi, S. Sakurai, K. Yamauchi and H. Inoue: Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea. Eur Respir J 34, 1390-1398 (2009)
42. K. C. Tan, W. S. Chow, J. C. Lam, B. Lam, W. K. Wong, S. Tam and M. S. Ip: HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184, 377-382 (2006) (Pubitemid 43049723)
43. S. Saarelainen, T. Lehtimaki, O. Jaak-kola, T. Poussa, M. Nikkila, T. Solakivi and M. M. Nieminen: Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea. Clin Chem Lab Med 37, 517-520 (1999) (Pubitemid 29304415)
44. M. Yamauchi, H. Nakano, J. Maekawa, Y. Okamoto, Y. Ohnishi, T. Suzuki and H. Kimura: Oxidative stress in obstructive sleep apnea. Chest 127, 1674-1679 (2005) (Pubitemid 46218794)
45. E. Vatansever, E. Surmen-Gur, A. Ursavas and M. Karadag: Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath (2010)
46. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni and P. J. Barnes: 8- Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124, 1386-1392 (2003) (Pubitemid 37290049)
47. S. Itzhaki, H. Dorchin, G. Clark, L. Lavie, P. Lavie and G. Pillar: The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 131, 740-749 (2007) (Pubitemid 46446865)
48. D. Monneret, J. L. Pepin, D. Godin-Ribuot, V. Ducros, J. P. Baguet, P. Levy and P. Faure: Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients. Free Radic Biol Med 48, 619-625 (2010)
49. V. Savransky, A. Nanayakkara, J. Li, S. Bevans, P. L. Smith, A. Rodriguez and V. Y. Polotsky: Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175, 1290-1297 (2007) (Pubitemid 46905755)
50. Y. J. Peng, J. Nanduri, G. Yuan, N. Wang, E. Deneris, S. Pendyala, V. Natarajan, G. K. Kumar and N. R. Prabhakar: NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci 29, 4903-4910 (2009)
51. G. Zhan, F. Serrano, P. Fenik, R. Hsu, L. Kong, D. Pratico, E. Klann and S. C. Veasey: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172, 921-929 (2005) (Pubitemid 41369078)
52. J. Jun, V. Savransky, A. Nanayakkara, S. Bevans, J. Li, P. L. Smith and V. Y. Polotsky: Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol 295, R1274-1281 (2008)
53. M. S. Hoffmann, P. Singh, R. Wolk, A. Romero-Corral, S. Raghavakaimal and V. K. Somers: Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. Antioxid Redox Signal 9, 661-669 (2007) (Pubitemid 46799098)
54. P. Faure, R. Tamisier, J. P. Baguet, A. Favier, S. Halimi, P. Levy and J. L. Pepin: Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J 31, 1046-1053 (2008)
55. A. Barcelo, F. Barbe, M. de la Pena, M. Vila, G. Perez, J. Pierola, J. Duran and A. G. Agusti: Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27, 756-760 (2006) (Pubitemid 44914199)
56. F. Wan and M. J. Lenardo: The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res 20, 24-33 (2010)
57. L. Lavie and V. Polotsky: Cardiovascular Aspects in Obstructive Sleep Apnea Syndrome - Molecular Issues, Hypoxia and Cytokine Profiles. Respiration 78, 361-370 (2009)
58. A. K. Htoo, H. Greenberg, S. Tongia, G. Chen, T. Henderson, D. Wilson and S. F. Liu: Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10, 43-50 (2006) (Pubitemid 44193436)
59. H. Greenberg, X. Ye, D. Wilson, A. K. Htoo, T. Hendersen and S. F. Liu: Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343, 591-596 (2006)
60. M. Yamauchi, S. Tamaki, K. Tomoda, M. Yoshikawa, A. Fukuoka, K. Makinodan, N. Koyama, T. Suzuki and H. Kimura: Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath 10, 189-193 (2006) (Pubitemid 44768845)
61. S. Jelic, D. J. Lederer, T. Adams, M. Padeletti, P. C. Colombo, P. H. Factor and T. H. Le Jemtel: Vascular inflammation in obesity and sleep apnea. Circulation 121, 1014-1021 (2010)
62. L. Dyugovskaya, A. Polyakov, D. Ginsberg, P. Lavie and L. Lavie: Molecular Pathways of Spontaneous and TNF-{alpha}-mediated Neutrophil Apoptosis Under Intermittent Hypoxia. Am J Respir Cell Mol Biol (2010)
63. S. Ryan, C. T. Taylor and W. T. McNicholas: Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174, 824-830 (2006) (Pubitemid 44511665)
64. L. Dyugovskaya, P. Lavie and L. Lavie: Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 1051, 340-350 (2005) (Pubitemid 41362764)
65. L. Lavie, L. Dyugovskaya and P. Lavie: Sleep-apnearelated intermittent hypoxia and atherogenesis: adhesion molecules and monocytes/endothelial cells interactions. Atherosclerosis 183, 183-184 (2005) (Pubitemid 41416838)
66. M. Winnicki, A. Shamsuzzaman, P. Lanfranchi, V. Accurso, E. Olson, D. Davison and V. K. Somers: Erythropoietin and obstructive sleep apnea. Am J Hypertens 17, 783-786 (2004) (Pubitemid 39201093)
67. L. Lavie, H. Kraiczi, A. Hefetz, H. Ghandour, A. Perelman, J. Hedner and P. Lavie: Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165, 1624-1628 (2002) (Pubitemid 34693942)
68. A. Valipour, B. Litschauer, F. Mittermayer, H. Rauscher, O. C. Burghuber and M. Wolzt: Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. Respir Med 98, 1180-1186 (2004) (Pubitemid 39497219)
69. G. L. Semenza and N. R. Prabhakar: HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 9, 1391-1396 (2007) (Pubitemid 47255018)
70. N. R. Prabhakar, G. K. Kumar and J. Nanduri: Intermittent hypoxia-mediated plasticity of acute O2 sensing requires altered red-ox regulation by HIF-1 and HIF-2. Ann N Y Acad Sci, 1177, 162-1688 (2009)
71. S. Ryan, C. T. Taylor and W. T. McNicholas: Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112, 2660-2667 (2005) (Pubitemid 41532603)
72. G. Yuan, J. Nanduri, C. R. Bhasker, G. L. Semenza and N. R. Prabhakar: Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280, 4321-4328 (2005) (Pubitemid 40288600)
73. S. Toffoli, O. Feron, M. Raes and C. Michiels: Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKAdependent regulation of HIF-1alpha. Biochim Biophys Acta 1773, 1558-1571 (2007) (Pubitemid 47498610)
74. V. Y. Polotsky, V. Savransky, S. Bevans-Fonti, C. Reinke, J. Li, D. N. Grigoryev and L. A. Shimoda: Intermittent and Sustained Hypoxia Induce a Similar Gene Expression Profile in the Human Aortic Endothelial Cells. Physiol Genomics (2010)
75. G. L. Semenza: Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1, 159-162 (2000)
76. J. Li, M. Bosch-Marce, A. Nanayakkara, V. Savransky, S. K. Fried, G. L. Semenza and V. Y. Polotsky: Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics 25, 450-457 (2006) (Pubitemid 43764766)
77. E. Belaidi, M. Joyeux-Faure, C. Ribuot, S. H. Launois, P. Levy and D. Godin-Ribuot: Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 53, 1309-1317 (2009)
78. R. S. Belaiba, S. Bonello, C. Zahringer, S. Schmidt, J. Hess, T. Kietzmann and A. Gorlach: Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18, 4691-4697 (2007) (Pubitemid 350246672)
79. S. R. Walmsley, C. Print, N. Farahi, C. Peyssonnaux, R. S. Johnson, T. Cramer, A. Sobolewski, A. M. Condliffe, A. S. Cowburn, N. Johnson and E. R. Chilvers: Hypoxiainduced neutrophil survival is mediated by HIF-1alphadependent NF-kappaB activity. J Exp Med 201, 105-115 (2005) (Pubitemid 40130088)
80. Y. Jung, J. S. Isaacs, S. Lee, J. Trepel, Z. G. Liu and L. Neckers: Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptorinteracting protein-dependent nuclear factor kappa B activation. Biochem J 370, 1011-1017 (2003) (Pubitemid 36399095)
81. P. Libby: Inflammation in atherosclerosis. Nature 420, 868-874 (2002) (Pubitemid 36019640)
82. J. Panes and D. N. Granger: Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114, 1066-1090 (1998) (Pubitemid 28217575)
83. L. Dyugovskaya, P. Lavie, M. Hirsh and L. Lavie: Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25, 820-828 (2005) (Pubitemid 40667679)
84. L. Dyugovskaya, P. Lavie and L. Lavie: Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168, 242-249 (2003) (Pubitemid 36920981)
85. J. Vinten-Johansen: Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61, 481-497 (2004) (Pubitemid 38210154)
86. T. Naruko, M. Ueda, K. Haze, A. C. van der Wal, C. M. van der Loos, A. Itoh, R. Komatsu, Y. Ikura, M. Ogami, Y. Shimada, S. Ehara, M. Yoshiyama, K. Takeuchi, J. Yoshikawa and A. E. Becker: Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106, 2894-2900 (2002) (Pubitemid 35424738)
87. N. Zidar, J. Jeruc, J. Balazic and D. Stajer: Neutrophils in human myocardial infarction with rupture of the free wall. Cardiovasc Pathol 14, 247-250 (2005) (Pubitemid 41317271)
88. P. Libby: Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65, S140-146 (2007)
89. K. Minoguchi, T. Tazaki, T. Yokoe, H. Minoguchi, Y. Watanabe, M. Yamamoto and M. Adachi: Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126, 1473-1479 (2004) (Pubitemid 39525019)
90. P. A. Vanderlaan and C. A. Reardon: Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 46, 829-838 (2005)
91. L. Song, C. Leung and C. Schindler: Lymphocytes are important in early atherosclerosis. J Clin Invest 108, 251-259 (2001) (Pubitemid 32656249)
92. L. Lavie, L. Dyugovskaya and A. Polyakov: Biology of peripheral blood cells in obstructive sleep apnea - the tip of the iceberg. Arch Physiol Biochem 114, 244-254 (2008)
93. G. Bokinsky, M. Miller, K. Ault, P. Husband and J. Mitchell: Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 108, 625-630 (1995)
94. T. Geiser, F. Buck, B. J. Meyer, C. Bassetti, A. Haeberli and M. Gugger: In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69, 229-234 (2002) (Pubitemid 34827837)
95. I. Eisensehr, B. L. Ehrenberg, S. Noachtar, K. Korbett, A. Byrne, A. McAuley and T. Palabrica: Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 51, 188-195 (1998) (Pubitemid 28345382)
96. D. S. Hui, F. W. Ko, J. P. Fok, M. C. Chan, T. S. Li, B. Tomlinson and G. Cheng: The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125, 1768-1775 (2004) (Pubitemid 38648410)
97. L. Nobili, G. Schiavi, E. Bozano, F. De Carli, F. Ferrillo and F. Nobili: Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22, 21-27 (2000) (Pubitemid 30139722)
98. J. J. Guardiola, P. J. Matheson, L. C. Clavijo, M. A. Wilson and E. C. Fletcher: Hypercoagulability in patients with obstructive sleep apnea. Sleep Med 2, 517-523 (2001) (Pubitemid 34026951)
99. W. H. Reinhart, J. Oswald, R. Walter and M. Kuhn: Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Clin Hemorheol Microcirc 27, 201-207 (2002) (Pubitemid 36160263)
100. C. Zamarron-Sanz, J. Ricoy-Galbaldon, F. Gude-Sampedro and A. Riveiro-Riveiro: Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Res 37, 552-555 (2006)
101. K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, N. Oda, A. Tanaka, M. Yamamoto, S. Ohta, C. P. O'Donnell and M. Adachi: Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 175, 612-617 (2007) (Pubitemid 46438946)
102. E. Ohga, T. Nagase, T. Tomita, S. Teramoto, T. Matsuse, H. Katayama and Y. Ouchi: Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87, 10-14 (1999) (Pubitemid 29330658)
103. A. Ursavas, M. Karadag, E. Rodoplu, A. Yilmaztepe, H. B. Oral and R. O. Gozu: Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 74, 525-532 (2007) (Pubitemid 47206882)
104. K. Chin, T. Nakamura, K. Shimizu, M. Mishima, T. Nakamura, M. Miyasaka and M. Ohi: Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109, 562-567 (2000)
105. L. Lavie: Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 23, 1059-1075 (2005) (Pubitemid 41503065)
106. S. Jelic, M. Padeletti, S. M. Kawut, C. Higgins, S. M. Canfield, D. Onat, P. C. Colombo, R. C. Basner, P. Factor and T. H. LeJemtel: Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117, 2270-2278 (2008)
107. A. A. El Solh, M. E. Akinnusi, I. G. Berim, A. M. Peter, L. L. Paasch and K. R. Szarpa: Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea. Sleep Breath 12, 331-337 (2008)
108. K. Martin, M. Stanchina, N. Kouttab, E. O. Harrington and S. Rounds: Circulating Endothelial Cells and Endothelial Progenitor Cells in Obstructive Sleep Apnea. Lung 186, 145-150 (2008)
109. M. de la Pena, A. Barcelo, F. Barbe, J. Pierola, J. Pons, E. Rimbau, O. Ayllon and A. G. Agusti: Endothelial Function and Circulating Endothelial Progenitor Cells in Patients with Sleep Apnea Syndrome. Respiration 76, 28-32 (2008) (Pubitemid 351914136)
110. L. Kheirandish-Gozal, R. Bhattacharjee, J. Kim, H. B. Clair and D. Gozal: Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med 182, 92-97 (2010)
111. J. H. von der Thusen, J. Kuiper, T. J. van Berkel and E. A. Biessen: Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 55, 133-166 (2003) (Pubitemid 36268401)
112. J. J. Haddad: Pharmaco-redox regulation of cytokinerelated pathways: from receptor signaling to pharmacogenomics. Free Radic Biol Med 33, 907-926 (2002) (Pubitemid 35284030)
113. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler, K. Hopper, A. Lotsikas, H. M. Lin, A. Kales and G. P. Chrousos: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85, 1151-1158 (2000) (Pubitemid 32269364)
114. J. Constantinidis, S. Ereliadis, N. Angouridakis, I. Konstantinidis, V. Vital and C. Angouridaki: Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol (2008)
115. P. M. Ridker, N. Rifai, M. Pfeffer, F. Sacks, S. Lepage and E. Braunwald: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101, 2149-2153 (2000) (Pubitemid 30253042)
116. T. Yokoe, K. Minoguchi, H. Matsuo, N. Oda, H. Minoguchi, G. Yoshino, T. Hirano and M. Adachi: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107, 1129-1134 (2003) (Pubitemid 36297204)
117. K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, A. Tanaka, N. Oda, S. Okada, S. Ohta, H. Naito and M. Adachi: Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172, 625-630 (2005) (Pubitemid 41232975)
118. E. Ohga, T. Tomita, H. Wada, H. Yamamoto, T. Nagase and Y. Ouchi: Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94, 179-184 (2003) (Pubitemid 36014310)
119. K. Nakamura, T. Ueno, H. Yamamoto, Y. Iguro, K. Yamada and R. Sakata: Relationship between cerebral injury and inflammatory responses in patients undergoing cardiac surgery with cardiopulmonary bypass. Cytokine 29, 95-104 (2005) (Pubitemid 40029605)
120. J. Davignon and P. Ganz: Role of endothelial dysfunction in atherosclerosis. Circulation 109, III27-32 (2004) (Pubitemid 38786440)
121. J. T. Willerson and P. M. Ridker: Inflammation as a cardiovascular risk factor. Circulation 109, II2-10 (2004)
122. L. Lavie, A. Hefetz, R. Luboshitzky and P. Lavie: Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21, 57-63 (2003) (Pubitemid 37204873)
123. R. Schulz, D. Schmidt, A. Blum, X. Lopes-Ribeiro, C. Lucke, K. Mayer, H. Olschewski, W. Seeger and F. Grimminger: Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55, 1046-1051 (2000)
124. M. S. Ip, B. Lam, L. Y. Chan, L. Zheng, K. W. Tsang, P. C. Fung and W. K. Lam: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162, 2166-2171 (2000) (Pubitemid 32051681)
125. J. T. Carlson, C. Rangemark and J. A. Hedner: Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 14, 577-584 (1996) (Pubitemid 26161112)
126. M. Kato, P. Roberts-Thomson, B. G. Phillips, W. G. Haynes, M. Winnicki, V. Accurso and V. K. Somers: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102, 2607-2610 (2000)
127. S. Itzhaki, L. Lavie, G. Pillar, G. Tal and P. Lavie: Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 28, 594-600 (2005) (Pubitemid 40677373)
128. H. Nagahama, M. Soejima, H. Uenomachi, Y. Higashi, K. Yotsumoto, T. Samukawa and T. Arima: Pulse wave velocity as an indicator of atherosclerosis in obstructive sleep apnea syndrome patients. Intern Med 43, 184-188 (2004) (Pubitemid 38489109)
129. L. F. Drager, L. A. Bortolotto, M. C. Lorenzi, A. C. Figueiredo, E. M. Krieger and G. Lorenzi-Filho: Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172, 613-618 (2005) (Pubitemid 41232973)
130. A. H. Friedlander, R. Yueh and M. R. Littner: The prevalence of calcified carotid artery atheromas in patients with obstructive sleep apnea syndrome. J Oral Maxillofac Surg 56, 950-954 (1998) (Pubitemid 28374241)
131. S. Jelic, M. N. Bartels, J. H. Mateika, P. Ngai, R. E. DeMeersman and R. C. Basner: Arterial stiffness increases during obstructive sleep apneas. Sleep 25, 850-855 (2002) (Pubitemid 35424527)
132. L. F. Drager, L. A. Bortolotto, A. C. Figueiredo, E. M. Krieger and G. F. Lorenzi: Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176, 706-712 (2007) (Pubitemid 47503079)
133. M. S. Ip, H. F. Tse, B. Lam, K. W. Tsang and W. K. Lam: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169, 348-353 (2004) (Pubitemid 38134813)
134. A. A. El Solh, R. Saliba, T. Bosinski, B. J. Grant, E. Berbary and N. Miller: Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 27, 997-1002 (2006) (Pubitemid 44911115)
135. M. Grebe, H. J. Eisele, N. Weissmann, C. Schaefer, H. Tillmanns, W. Seeger and R. Schulz: Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173, 897-901 (2006)
136. L. Lavie and P. Lavie: Coronary collateral circulation in sleep apnea: a cardioprotective mechanism? Chest 137, 511-512 (2010)
137. S. Steiner, P. O. Schueller, V. Schulze and B. E. Strauer: Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 137, 516-520 (2010)
138. P. Lavie and L. Lavie: Unexpected survival advantage in elderly people with moderate sleep apnoea. J Sleep Res 18, 397-403 (2009)